F. Pojer

Discipline

Economies et finances (2)

Type de document

Articles (10)

Co-auteur

Date

Source

Mot-clé

enzyme (5) Human beings (4) protéine (3) modèle (3) infection (3) immunité (3) Protein binding (3) Mice (3) Infection (3) Immunoglobulins (3) Immunity (3) Immune response (3) Example (3) virus (2) thérapie (2) spectacle (2) microscopie (2) métabolisme (2) anticorps (2) maladie (2) cancer (2) Treatment (2) Control (2) Cancer (2) Inhibitors (2) Drama (2) Microscopy (2) Kynurenine (2) Tryptophan (2) X-ray crystallography (2)

Documents écrit par F. Pojer (10) | parle de F. Pojer (0)

Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.
J. Racle et al. (13 juin 2023)
Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range.
D. Ni et al.
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
M. Emmenegger et al. (17 févr. 2023)
Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
U.F. Röhrig et al.
A highly potent antibody effective against SARS-CoV-2 variants of concern.
C. Pellaton et al. (12 oct. 2021)
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.
C. Fenwick et al. (4 août 2021)
Author Correction: Internalization and vacuolar targeting of the brassinosteroid hormone receptor BRI1 are regulated by ubiquitination.
S. Martins et al. (17 mai 2021)
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
U.F. Röhrig et al. (25 févr. 2021)
Dual role for ubiquitin in plant steroid hormone receptor endocytosis
S. Martins et al. (2015)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
V. Makarov et al. (2014)